Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) Net Income towards Common Stockholders (2017 - 2025)

Catheter Precision has reported Net Income towards Common Stockholders over the past 9 years, most recently at -$7.7 million for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 29.0% to -$7.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$21.1 million through Dec 2025, up 3.21% year-over-year, with the annual reading at -$17.2 million for FY2025, 21.18% up from the prior year.
  • Net Income towards Common Stockholders was -$7.7 million for Q4 2025 at Catheter Precision, down from -$2.3 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $3.1 million in Q3 2021 and troughed at -$67.2 million in Q1 2023.
  • The 5-year median for Net Income towards Common Stockholders is -$4.8 million (2022), against an average of -$7.6 million.
  • Year-over-year, Net Income towards Common Stockholders soared 1266.67% in 2021 and then crashed 1512.26% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $3.1 million in 2021, then crashed by 364.9% to -$8.2 million in 2022, then surged by 91.8% to -$669000.0 in 2023, then crashed by 1512.26% to -$10.8 million in 2024, then increased by 29.0% to -$7.7 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Net Income towards Common Stockholders are -$7.7 million (Q4 2025), -$2.3 million (Q3 2025), and -$6.4 million (Q2 2025).